Literature DB >> 17523748

Clinical observations of sertindole in 53 hospitalised patients with psychotic disorders.

Tilman Steinert1, Barbara Hauger, Jürgen Eckardt, Peter Schmid.   

Abstract

Entities:  

Year:  2005        PMID： 17523748     DOI： 10.2165/00044011-200525010-00007

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  9 in total

1.  Pharmacological profile of the atypical neuroleptic sertindole.

Authors:  J Hyttel; J Arnt; B Costall; A Domeney; N Dragsted; H L Lembøl; E Meier; R J Naylor; G Nowak; C Sánchez
Journal:  Clin Neuropharmacol       Date:  1992       Impact factor: 1.592

2.  A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia.

Authors:  D P van Kammen; J P McEvoy; S D Targum; D Kardatzke; T B Sebree
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

Review 3.  Sertindole, a new atypical antipsychotic for the treatment of schizophrenia.

Authors:  L A Brown; G M Levin
Journal:  Pharmacotherapy       Date:  1998 Jan-Feb       Impact factor: 4.705

4.  Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.

Authors:  D G Daniel; P Wozniak; R J Mack; B G McCarthy
Journal:  Psychopharmacol Bull       Date:  1998

Review 5.  Sertindole in the treatment of psychosis in schizophrenia: efficacy and safety.

Authors:  C A Tamminga; R J Mack; G R Granneman; C J Silber; K B Kashkin
Journal:  Int Clin Psychopharmacol       Date:  1997-02       Impact factor: 1.659

6.  The atypical antipsychotic sertindole: a case series.

Authors:  A M Lee; J L Knoll; T Suppes
Journal:  J Clin Psychiatry       Date:  1997-09       Impact factor: 4.384

7.  Sertindole improves both the positive and negative symptoms of schizophrenia: Results of a phase III trial.

Authors:  A Hale Jean-Michel Azorin Siegfried Kasper Wolfgang Maier Erkka Syvalahti Michael Van Der Burght Mogens Sloth-Nielsen Allan Wehnert
Journal:  Int J Psychiatry Clin Pract       Date:  2000       Impact factor: 1.812

8.  Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.

Authors:  D L Zimbroff; J M Kane; C A Tamminga; D G Daniel; R J Mack; P J Wozniak; T B Sebree; B A Wallin; K B Kashkin
Journal:  Am J Psychiatry       Date:  1997-06       Impact factor: 18.112

9.  The acute effect of sertindole on brain 5-HT2, D2 and alpha 1 receptors (ex vivo radioreceptor binding studies).

Authors:  J Hyttel; J B Nielsen; G Nowak
Journal:  J Neural Transm Gen Sect       Date:  1992
  9 in total
  2 in total

1.  Emerging role of sertindole in the management of schizophrenia.

Authors:  Stephanie L Cincotta; Joshua S Rodefer
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

Review 2.  Sertindole : a review of its use in schizophrenia.

Authors:  David Murdoch; Gillian M Keating
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.